首页> 外文期刊>Experimental and clinical transplantation >Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient
【24h】

Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient

机译:成年患者严重Glanzmann血小板减少症中的干细胞移植。

获取原文
       

摘要

Glanzmann thrombasthenia is an inherited auto-somal recessive disorder characterized by normal platelet count but lack of platelet aggregation due to absence of platelet glycoprotein IIb/IIIa. The disease usually is associated with mild bleeding, but severe fatal hemorrhage may occur. Allogeneic stem cell transplant is the only curative method of treatment. A literature search showed 18 previously reported cases of Glanzmann thrombasthenia treated with allogeneic hematopoietic stem cell transplant. We report an 18-year-old woman with severe Glanzmann thrombasthenia who was treated with allogeneic hematopoietic stem cell transplant from her sister. After 24-month follow-up, the patient was well, had no bleeding tendency, and had mild chronic skin graft-versus-host disease.
机译:格兰兹曼血栓性衰弱是一种遗传性自身体质性隐性疾病,其特征是血小板计数正常,但由于缺乏血小板糖蛋白IIb / IIIa而导致血小板聚集不足。该疾病通常与轻度出血有关,但可能发生严重的致命性出血。同种异体干细胞移植是唯一的治疗方法。文献检索显示,用异基因造血干细胞移植治疗的18例先前报道的Glanzmann血虚症患者。我们报道了一名18岁重度格兰仕曼(Glanzmann)血虚症的妇女,她的妹妹接受了同种异体造血干细胞移植治疗。随访24个月后,患者情况良好,没有出血倾向,并且患有轻度慢性皮肤移植物抗宿主病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号